Management of Severe HDFN due to Maternal Anti-Rh17: Supporting infants with Incompatible Blood

preprint OA: closed
View at publisher

Abstract

The main antigens in the Rh blood group system are D, C, c, E and e 1 . D– is a rare type that lacks C,c,E,e antigens, elevating D on RBC surface 2 . Alloimmunization to anti-Rh17 causes severe HDFN 4 . We report a case of Rh17 alloimmunization, treated with incompatible blood. Prenatal therapies included plasma exchange, intravenous immunoglobulin (IVIG) and intrauterine transfusions (IUTs). The infant, delivered at 32 weeks, experienced hyperbilirubinemia and anemia, managed with transfusions and medications. Due to the rarity of the condition, finding compatible blood is challenging, necessitating management with incompatible blood in severe HDFN cases, as exemplified in our case.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00